Skip to main navigation Skip to search Skip to main content

PRECISION 1: A phase 2, multicenter, open-label basket trial of nab-sirolimus for malignant solid tumors harboring pathogenic inactivating alterations in TSC1 and TSC2.

  • Dustin A. Deming
  • , David J. Kwiatkowski
  • , Li Ding
  • , Anita N. Schmid
  • , Willis H. Navarro
  • , Jordi Rodon Ahnert
  • , Gopa Iyer

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'PRECISION 1: A phase 2, multicenter, open-label basket trial of nab-sirolimus for malignant solid tumors harboring pathogenic inactivating alterations in TSC1 and TSC2.'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology